Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation

Journal of Molecular Endocrinology

Volumn 40, Issue 1-2, 2008, Pages 75-91

  Kimura, Nobuko ^a   Takamatsu, Nobuko ^a   Yaoita, Yoshio ^b   Osamura, R Yoshiyuki ^c   Kimura, Narimichi ^d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b Department of Biological Science   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 2; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR; ESR1 PROTEIN, HUMAN; ESTRADIOL; SOMATOSTATIN RECEPTOR 2; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DROSOPHILA; ESTROGEN RESPONSIVE ELEMENT; EXON; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENETIC TRANSFECTION; HELA CELL; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY SEQUENCE; TRANSCRIPTION REGULATION; ANIMAL; CYTOLOGY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; DROSOPHILA MELANOGASTER; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTAGENESIS; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

5' FLANKING REGION; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DROSOPHILA MELANOGASTER; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS; RECEPTORS, SOMATOSTATIN; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RESPONSE ELEMENTS; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION INITIATION SITE;

EID: 39549088902     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-07-0108     Document Type: Article

References (59)

1. Ben-Shlomo A, Wawrowsky KA, Proekt I, Wolkenfeld NM, Ren S-G, Taylor J, Culler MD & Melmed S 2005 Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion. Journal of Biological Chemistry 280 24011-24021.
2. Bouyer K, Loudes C, Robinson ICAF, Epelbaum J & Faivre-Bauman A 2006 Sexually dimorphic distribution of sst2A somatostatin receptors on growth hormone-releasing hormone neurons in mice. Endocrinology 147 2670-2674.
3. Campbell-Thompson M, Reyher KK & Wilkinson LB 2001 Immunolocalization of estrogen receptor alpha and beta in gastric epithelium and enteric neurons. Journal of Endocrinology 171 65-73.
4. Carrere N, Vernejoul F, Souque A, Asnacios A, Vaysse N, Pradayrol L, Susini C, Buscail L & Cordelier P 2005 Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells. Human Gene Therapy 16 1175-1193.
5. Carroll JS & Brown M 2006 Estrogen receptor target gene: an evolving concept. Molecular Endocrinology 20 1707-1714.
6. Castro-Rivera E, Samudio I & Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. Journal of Biological Chemistry, 276 30853-30861.
7. Cha-Molstad H, Keller DM, Yochum GS, Impey S & Goodman RH 2004 Cell-type-specific binding of the transcription factor CREB to the cAMP-response element. PNAS 101 13572-13577.
8. Coleman TA, Hou YT & Kopchick JJ 1992 The SV40 early transcriptional regulatory element is unable to direct gene expression in pituitary GH3 cells. Gene Expression 2 175-189.
9. Courey AJ & Tjian R 1988 Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55 887-896.
10. Dalm VA, van Hagen PM, van Koetsveld PM, Langerak AW, van der Lely AJ, Lamberts SW & Hofland LJ 2003 Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. Journal of Clinical Endocrinology and Metabolism 88 270-276.
11. Van Dam H & Castellazzi M 2001 Distinct roles of Jun:Fos and Jun:ATF dimmers in oncogenesis. Oncogene 20 2453-2464.
12. Day RN & Maurer RA 1989 The distal enhancer region of the rat prolactin gene contains elements conferring response to multiple hormones. Molecular Endocrinology 3 3-9.
13. 99mTc-depreotide. European Journal of Nuclear Medicine and Molecular Imaging 31 1022-1030.
14. 99mTc-depreotide scintigraphy. Journal of Nuclear Medicine 47 6-13.
15. Deroo BJ & Korach KS 2006 Estrogen receptors and human disease. Journal of Clinical Investigation 116 561-570.
16. Djordjijevic D, Zhang J, Priam M, Viollet C, Gourdji D, Kordon C & Epelbaum J 1998 Effect of 17β-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Endocrinology 139 2272-2277.
17. Dorflinger U, Pscherer A, Moser M, Rummele P, Schule R & Buettner R 1999 Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain. Molecular and Cellular Biology 19 3736-3747.
18. Dougherty SM, Mazhawidza W, Bohn AR, Robinson KA, Mattingly KA, Blankenship KA, Huff MO, McGregor WG & Klinge CM 2006 Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells. Endocrine-Related Cancer 13 113-134.
19. Dutar P, Vaillend C, Viollet C, Billard JM, Potier B, Carlo AS, Ungerer A & Epelbaum J 2002 Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice. Neuroscience 112 455-466.
20. Fujita N, Kajita M, Taysavang P & Wade PA 2004 Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Molecular Endocrinology 18 2937-2949.
21. Hagen G, Muller S, Beato M & Suske G 1992 Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Research 20 5519-5525.
22. Halmos G, Schally AV, Sun B, Davis R, Bostwick DG & Plonowski A 2000 High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers. Journal of Clinical Endocrinology and Metabolism 85 2564-2571.
23. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kei AE, Kei OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA et al. 1998 Database on transcriptional regulation: TRANSFAC, TRRD, and CMPEL. Nucleic Acids Research 26 362-367.
24. Higgins KJ, Liu S, Abdelrahim M, Yoon K, Vanderlaag K, Porter W, Metz RP & Safe S 2006 Vascular endothelial growth factor receptor-2 expression is induced by 17β-estradiol in ZR-75 breast cancer cells by estrogen receptor α/Sp proteins. Endocrinology 147 3285-3295.
25. Hofland LJ & Lamberts SW 2003 The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocrine Reviews 24 28-47.
26. Jordan VC & Morrow M 1999 Tamoxifen, raloxifene and the prevention of breast cancer. Endocrine Reviews 20 253-278.
27. Kietz S, Thomsen JS, Matthews J, Pettersson K, Strom A & Gustafsson J-A 2004 The Ah receptor inhibits estrogen-induced estrogen receptor β in breast cancer cells. Biochemical and Biophysical Research Communications 320 76-82.
28. Kimura N & Takamatsu N 2002 Analysis of a novel promoter region of the human somatostatin receptor sst2 gene (Abstract, Japanese): Proceeding of the 29th Annual Meeting of The Japan Neuroendocrine Society, 2002, Kochi, Japan. Folia Endocrinologica Japonica 78 313.
29. Kimura N, Hayafuji C, Konagaya H & Takahashi K 1986 17-β-Estradiol-induced somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology 119 1028-1036.
30. Kimura N, Hayafuji C & Kimura N 1989 Characterization of 17-β-estradiol-dependent and -independent somatostatin receptor subtypes in rat anterior pituitary. Journal of Biological Chemistry 264 7033-7040.
31. Kimura N, Tomizawa S, Arai KN & Kimura N 1998 Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA), but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology 139 1573-1580.
32. Kimura N, Tomizawa S, Arai KN. Osamura RY & Kimura N 2001 Characterization of 5′-flanking region of rat somatostatin receptor sst2 gene: transcriptional regulatory elements and activation by Pitx1 and estrogen. Endocrinology 142 1427-1441.
33. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Research 29 2905-2919.
34. Krantic S, Goddard I, Saveanu A, Giannetti N, Fombonne J, Cardoso A, Jaquet P & Enjalbert A 2004 Novel modalities of somatostatin actions. European Journal of Endocrinology 151 643-655.
35. Kraus J, Woltje M, Schonwetter N & Hollt V 1998 Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene. FEBS Letters 428 165-170.
36. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F & Giguere V 2005 Location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response. PNAS 102 11651-11656.
37. Martinez V, Curi AP, Torkian B, Schaeffer JM, Wilkinson HA, Walsh JH & Tache Y 1998 High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology 114 1125-11327.
38. 99mTc-DS predicts response to endocrine therapy in advanced breast cancer patients. Nature Clinical Practice. Oncology 3 174.
39. Noti JD 1997 Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11c and CD11b and cooperates with c-jun to activate CD11c. Journal of Biological Chemistry 272 24038-24045.
40. Ogawa S, Inoue S, Watanabe T, Hiroi H, Orimo A, Hosoi T, Ouchi Y & Muramatsu M 1998 The complete primary structure of human estrogen receptor β (hERβ) and its heterodimerization with ERα in vivo and in vitro. Biochemical and Biophysical Research Communications 243 122-126.
41. Ohashi M, Aizawa S, Ooka H, Ohsawa T, Kaji K, Kondo H, Kobayashi T, Noumura T, Matsuo M, Mitsui Y et al. 1980 A new human diploid cell strain, TIG-1, for the research on cellular aging. Experimental Gerontology 15 121-133.
42. Olias G, Viollet C, Kusserow H, Epelbaum J & Meyerhof W 2004 Regulation and function of somatostatin receptors. Journal of Neurochemistry 89 1057-1091.
43. O'Lone R, Frith MC, Karlsson EK & Hansen U 2004 Genomic targets of nuclear estrogen receptors. Molecular Endocrinology 18 1859-1875.
44. Orlando C, Casini Raggi C, Bianchi S, Distante V, Simi L, Vezzosi V, Gelmini S, Pinzani P, Cameron Smith M, Buonamano A et al. 2004 Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. Endocrine-Related Cancer 11 323-332.
45. Patel YC 1999 Somatostatin and its receptor family. Frontiers in Neuroendocrinology 20 157-198.
46. Petersenn S, Rasch AC, Presch S, Beil FU & Schulte HM 1999 Genomic structure and transcriptional regulation of the human somatostatin receptor type 2. Molecular and Cellular Endocrinology 157 75-85.
47. Pscherer A, Dorflinger U, Kirfel J, Gawlas K, Ruschoff J, Buettner R & Schule R 1996 The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO Journal 15 6680-6690.
48. Puente E, Saint-Laurent N, Torrisani J, Furet C, Schally AV, Vaysse N, Buscail L & Susini C 2001 Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-β. Involvement of Smad4. Journal of Biological Chemistry 276 13461-13468.
49. Ren S-G, Taylor J, Dong J, Yu R, Culler MD & Melmed S 2003 Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. Journal of Clinical Endocrinology and Metabolism 88 4239-4245.
50. Reubi JC 2003 Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocrine Reviews 24 389-427.
51. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitamins and Hormones 62 231-252.
52. Shimizu T, Kamegai J, Tamura H, Ishii S, Sugihara H & Oikawa S 2005 The estrogen receptor (ER) α, but not ER β, gene is expressed in hypothalamic growth hormone-releasing hormone neurons of the adult female rat. Neuroscience Research 52 121-125.
53. Stoner M, Wang F, Wormke M, Nguyen T, Samudio I, Vyhlidal C, Marme D, Finkenzeller G & Safe S 2000 Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor α and Sp3 proteins. Journal of Biological Chemistry 275 22769-22779.
54. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF et al. 2002 Generation and initial analysis of more than 15 000 full-length human and mouse cDNA sequences. PNAS 99 16899-16903.
55. Suske G 1999 The Sp-family of transcription factors. Gene 238 291-300.
56. Xu Y, Song J, Berelowitz M & Bruno JF 1996 Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology 137 5634-5640.
57. Xu Y, Berelowitz M & Bruno JF 1998 Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness. Molecular and Cellular Endocrinology 139 71-77.
58. Yamada Y, Post SR, Wang K, Tager HS, Bell GI & Seino S 1992 Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. PNAS 89 251-255.
59. Zheng H, Bailey A, Jiang MH, Honda K, Chen HY, Trumbauer ME, Van der Ploeg LH, Schaeffer JM, Leng G & Smith RG 1997 Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Molecular Endocrinology 11 1709-1717.